An affiliate of private equity firm HIG Capital has completed a strategic investment in Assistência Multidisciplinar em Oncologia (AMO), an independent oncology clinic in Brazil and a nationally recognised provider of cancer treatment.
Headquartered in Salvador, and with eight clinics in the State of Bahia, AMO is the largest oncological service provider in the State, offering comprehensive cancer treatments to patients in partnership with a large clinical team and several local hospitals. With recognised quality and patient-centric care, the Company is among a selected group of seven organisations outside the US with a distinguished quality certification from the American Society of Clinical Oncology (ASCO).
Fernando Marques Oliveira, Managing Director and Head of HIG Brazil and Latin America, says: “We are very pleased to partner with AMO. The founding shareholders and management team have done a remarkable job and built one of the most recognised oncology outpatient facilities in Brazil. We look forward to working with the AMO team to capitalise on its growth opportunities, which will expand availability of high quality cancer care in the country.”
“It was very important for us to find the right investor who shared our vision to provide compassionate, comprehensive and quality care to patients. HIG’s team stood out as the right fit for us given their collaborative approach, sector knowledge, as well as their experience on both local and global levels. We are thrilled to have them as a partner to accelerate the Company’s growth,” says Carlos Sampaio, founding shareholder and Chairman of the Board of AMO.
